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1  | INTRODUC TION
Thoracic	 aortic	 aneurysm	 (TAA)	 is	 typically	 clinically	 silent.	Very	










used	 for	diagnostic	 imaging	of	 the	aorta.	TTE	excels	 in	 temporal	
resolution,	 is	harmless,	cheap	and	can	be	used	in	any	clinical	set‐
ting,	but	it	will	not	show	the	entire	thoracic	aorta.	Especially,	the	











inal	 aortic	 aneurysms	 which	 favor	 ultrasound.6,7	 The	 American	
Society	of	Echocardiography	(ASE)	and	the	European	Association	
of	Cardiovascular	Imaging	(AECI)4	choose	TTE	as	first	choice,	but	



























All	 consecutive	 adults	 scheduled	 for	 screening	 of	 thoracic	 aor‐
tic	 disease	 in	 a	 specialized	 tertiary	 cardiology	 outpatient	 clinic	





were:	 (1)	 age	 ≥15	years,	 (2)	 first	 visit	 to	 the	 outpatient	 clinic	 of	
thoracic	 aortic	 disease	 and	 (3)	 screening	 as	 reason	 of	 referral.	
The	 decision	which	 imaging	modality	was	 indicated	 for	 patients	
was	 based	on	 clinical	 experience	 and	 preference	 of	 the	 treating	
physician	 (JR,	 JC,	or	RM).	Demographic,	 clinical,	 and	 family	data	
together	with	 information	about	genetic	testing10	were	obtained	
from	 the	 electronic	 patient	 files.	 Hypertension,	 hypercholester‐
olemia,	and	diabetes	mellitus	were	defined	as	current	use	of	med‐





On	CT,	 the	 aortic	 diameters	were	measured	 following	 a	 standard	
protocol	at	the	level	of	the	sinus	of	Valsalva	(SoV),	ascending	aorta,	
aortic	 arch,	 and	 descending	 aorta.	 Both	 the	 ascending	 aorta	 (AA)	
and	descending	aorta	 (DA)	were	measured	at	 the	maximum	diam‐
eter	(mostly	at	the	level	of	the	left	atrium	or	pulmonary	bifurcation).	
On	TTE,	 the	diameters	of	 the	SoV	and	AA	 (largest	diameter)	were	
measured	and	compared	with	CT	measurements.
2.2 | Transthoracic echocardiography
Standard	 two‐dimensional	 TTE	 was	 performed	 by	 experienced	
sonographers,	following	a	standard	protocol.	All	studies	were	ac‐
quired	 using	 harmonic	 imaging	 on	 an	 iE33	 or	 EPIQ7	 ultrasound	
system	(Philips	Medical	Systems,	Best,	The	Netherlands)	equipped	
with	an	×5‐1	matrix‐array	transducer	(composed	of	3040	elements	
operating	 at	 1‐5	MHz).	 The	 aorta	was	measured	 in	 the	 standard	
parasternal	 long‐axis	 view	 and	 acquisition	 of	 the	 long‐axis	 view	
performed	 from	 a	 different	 intercostal	 space	 or	 at	 a	 different	
distances	from	the	sternal	border	to	improve	the	visualization	of	
the	 ascending	 aorta.11	 The	measurements	were	performed	 from	
leading	 edge‐to‐leading	 edge	 during	 diastole.	 The	 presence	 of	 a	
bicuspid	aortic	 valve	was	assessed	on	TTE	and	classified	as	yes,	
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analyzed	 using	Curad	off‐line	 software	 (version	3.5.3.0,	Wijk	 bij	
Duurstede,	The	Netherlands).
2.3 | Computed tomography
Contrast‐enhanced	 CT	 scans	 of	 the	 entire	 aorta	 were	 obtained	
with	standard	acquisition	protocols	on	a	variety	of	scanners	includ‐
ing	both	the	thoracic	and	abdominal	aorta	until	the	femoral	artery.	
Overall	 202/226	 (89%)	of	 the	 scans	were	performed	on	 a	 second	
or	 third	 generation	 dual	 source	 scanner	 (Flash,	 Drive	 and	 Force,	
Siemens	 Healthineers,	 Erlangen,	 Germany)	 most	 commonly	 with	
a	high‐pitch	acquisition	 in	183/226	 (81%)	 scans.	For	193/226,	 the	
phase	 of	 the	 RR	 interval	 was	 available	 and	 ranged	 between	 20%	
and	 70%.	 The	 aortic	 diameters	were	measured	 using	 the	 double‐
oblique	technique	perpendicular	to	the	vessel	axis	and	the	SoV	was	
measured	as	 the	cusp‐to‐commissure	distance,	because	 this	 is	 the	
method	most	often	used.4	Arterial	anomalies	were	divided	into	an‐
eurysm,	stenosis,	and	dissection	located	in	the	thorax	or	abdomen.	
We	used	 the	 following	definitions	 for	 clinical	 relevant	 aneurysms:	
aortic	 root	 ≥40	mm,13	 ascending	 and	 descending	 aorta	 ≥40	mm,13 
pulmonary	 artery	 ≥30	mm,14	 abdominal	 aorta	 ≥30	mm,15	 splenic,	













ables	 are	 presented	 as	 frequencies	with	percentages.	Comparison	
of	 categorical	 variables	was	done	using	 the	 chi‐square	 test	 and	 in	

















other	 patients	 were	 referred	 because	 of	 an	 incidentally	 detected	




























TGFB3	 gene	 (n	=	5).	 These	 genetic	mutations	were	 either	 the	 rea‐
son	 for	 screening	or	 found	 as	 a	 result	 of	 screening.	 In	132	of	 the	
349	 patients	 (38%)	 the	 family	 history	 was	 negative,	 107	 patients	
(31%)	 had	 a	 first‐degree	 or	 second‐degree	 family	 member	 with	 a	
TAA,	57	patients	 (16%)	had	a	first‐degree	or	second‐degree	family	
member	with	a	thoracic	aortic	dissection	and	53	patients	(15%)	had	
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3.2 | Aortic diameter
In	 total,	 in	 47	 patients	 (13%)	 the	 proximal	 aorta	 (SoV	 or	 AA)	was	
≥40	mm	on	TTE	or	CT	and	in	2	patients	(0.6%)	it	was	≥50	mm.	In	pa‐
tients	who	underwent	both	TTE	and	CT,	the	diameter	of	the	SoV	was	









TA B L E  1  Baseline	characteristics	screening	patients
Total (n = 349)
Patients with echocardiography 
alone (n = 123)
Patients with echocardiography 
and CT imaging (n = 226) P value
Age	(y) 41	±	15 32	±	12 46	±	15 .000
Female 194	(56%) 71	(58%) 123	(54%) .553
Height	(cm) 176	±	11 178	±	12 175	±	11 .034
Weight	(kg) 77	±	17 73	±	18 79	±	16 .009
Systolic	blood	pressure	(mm	Hg) 130	±	19 125	±	16 133	±	19 .000
Diastolic	blood	pressure	(mm	Hg) 81	±	12 78	±	11 83	±	13 .001
Hypertension 44	(13%) 4	(3%) 40	(18%) .000*
Hypercholesterolemia 7	(2%) 0	(0%) 7	(3%) .055*
Diabetes	mellitus	type	2 7	(2%) 2	(2%) 5	(2%) 1.000*
Beta‐blockers 25	(7%) 5	(4%) 20	(9%) .098
Diuretics 27	(8%) 2	(2%) 25	(11%) .001*
ACE	inhibitors 12	(3%) 0	(0%) 12	(5%) .010*
Values	are	given	in	mean	±SD	or	n	(%).
*Fisher’s	exact	test.	
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of	the	SoV	could	not	be	measured	with	echo	in	one	patient	due	to	
insufficient	 image	quality	 and	with	CT	 in	 four	patients	due	 to	 the	
absence	of	contrast.	The	ascending	aorta	could	not	be	imaged	with	
echo	 in	 nine	 cases	 because	 of	 unfavorable	 aortic	 anatomy	 in	 the	
chest	or	 high	BMI.	At	 SoV	 level,	 the	difference	between	TTE	and	
CT	was	≥5	mm	in	14%	with	a	maximum	difference	of	8	mm,	while	at	
AA	level	a	difference	of	≥5	mm	was	found	in	14%	with	a	maximum	
difference	 of	 11	mm.	With	multiple	 linear	 regression	 analysis,	 age	
was	positively	associated	with	the	difference	 in	diameter	between	
CT	 and	 echocardiography	 for	 both	 the	 level	 of	 the	 SoV	 (P	=	.004)	









3.3 | Additional findings on echocardiography and 
computed tomography









patients	 (4%	 of	 all	 patients):	 dissection	 of	 the	 renal	 artery	 in	 one	
patient,	 dilation	of	 the	pulmonary	 artery	 (≥30	mm)	 in	 six	 patients,	
dilation	of	the	aortic	arch	in	one	patient,	dilation	of	the	abdominal	
aorta	 (32	mm)	 in	one	patient	and	one	patient	had	a	dilation	of	 the	
femoral	artery	(36	mm)	as	well	as	a	dilation	of	the	abdominal	aorta	
(32	mm).	This	 last	 patient	needed	preventive	 surgery	 for	 the	 fem‐
oral	 artery	 aneurysm.	 Of	 the	 10	 patients	 with	 clinically	 relevant	
peripheral	arterial	abnormalities,	six	patients	also	showed	a	SoV	or	
AA	 of	 ≥40	mm.	 All	 patients	 with	 clinically	 relevant	 abnormalities	
are	shown	in	Table	3.	The	presence	of	an	aneurysm	of	the	proximal	







screening	 received	both	TTE	and	CT	 (65%).	 In	our	cohort,	dilation	
(≥40	mm)	of	 the	aortic	 root	or	ascending	aorta	was	 found	 in	13%,	
intracardiac	abnormalities	were	detected	in	7%,	and	relevant	other	
arterial	abnormalities	in	4%.
4.1 | Accuracy of TTE and CT to establish 
aortic dilation
The	 mean	 difference	 of	 the	 proximal	 aortic	 diameter	 measured	
with	 TTE	 vs	 CT	 was	 small,	 but	 large	 differences	 were	 found	 in	
individual	 patients	with	 a	 difference	 of	 up	 to	 8	mm	 for	 the	 SoV	



































































We	 used	 the	 cusp‐to‐commissure	 method,	 because	 by	 CT	 or	
MRI	the	aortic	root	is	measured	most	often	between	the	inner	edges	
from	commissure	to	opposite	sinus.4	There	 is	still	no	consensus	 in	
the	 guidelines	 how	 to	measure	 the	 aortic	 root	 at	 the	 level	 of	 the	



















4.2 | Should TTE be a part of routine screening?
An	argument	 in	favor	of	using	TTE	as	screening	tool	would	be	the	
ability	 to	detect	 intracardiac	abnormalities,	 including	valve	pathol‐
ogy	and	ventricular	hypertrophy	or	dilation.	In	our	study,	concomi‐
tant	 cardiac	 abnormalities	 were	 rarely	 found	 on	 TTE.	 A	 bicuspid	
aortic	valve	was	present	 in	2%	of	 the	patients,	which	 is	 compara‐
ble	to	the	general	population.27,28	In	our	specific	group	of	patients,	








4.3 | Additional vascular abnormalities on CT
In	 patients	 referred	 for	 screening	 who	 underwent	 CT,	 we	 found	
peripheral	arterial	pathology	 in	15%,	predominantly	 located	 in	 the	
abdomen.	Eleven	of	these	pathologies	(4%	of	all	patients)	were	clini‐
cally	relevant.	We	showed	that	aneurysms	of	the	SoV	and/or	ascend‐
ing	 aorta	 are	 associated	with	 abnormalities	 in	 other	 intrathoracic,	
F I G U R E  2  Vascular	abnormalities	or	variants	found	with	CT.	Vascular	abnormalities	or	variants	found	in	scanned	area	(gray	rectangle)	
with	CT	while	patients	came	for	thoracic	aortic	pathology	screening.	Thorax	alone	was	scanned	in	12	patients	and	in	214	patients	both	
thorax	and	abdomen	were	scanned.	When	we	only	include	the	clinical	relevant	aneurysms,	we	found	11	abnormalities	(4%	of	all	patients)
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abdominal,	or	more	peripheral	 arteries.	This	 is	well	 known	 for	pa‐





4.4 | Which imaging technique in which patient?
Every	patient	referred	for	aortic	screening	should	have	an	accurate	












in	our	opinion	 the	 clinical	 relevance	of	 correctly	diagnosing	aortic	
pathology	warrants	optimal	 imaging.	Of	 course	MRI	has	 the	great	
advantage	 of	 not	 exposing	 the	 patient	 to	 radiation	 at	 all	 and	 this	
technique	 should	be	used	 in	 children	when	possible.	The	11	 clini‐
cally	 relevant	arterial	abnormalities	 listed	 in	Table	3	are	 located	 in	
the	larger	arteries	and	would	likely	have	been	picked	up	by	an	MRI	
vasculopathy	study,	which	would	be	an	argument	for	MRI.
In	 patients	 where	 aortic	 dilatation	 is	 diagnosed	 follow‐up	 is	
needed	 to	 identify	 further	growth	of	 the	aorta.	 In	patients	where	
echocardiography	is	able	to	visualize	the	aortic	root	and	ascending	
aorta	 sufficiently,	 echocardiography	 can	 be	 used	 as	 imaging	 tool	
during	follow‐up.	However,	when	TTE	cannot	be	used,	MRI	is	pre‐
ferred,	especially	 in	younger	patients.	Preferably,	follow‐up	should	









the	diagnostic	 value	of	CT	 as	 an	 imaging	 tool.	 Intracardiac	 abnor‐
malities	were	not	common	in	patients	who	were	sent	for	screening	
of	thoracic	aortic	pathology.	Although	TTE	is	a	suboptimal	imaging	
technique	 for	aortic	 screening,	 it	may	be	used	 to	detect	 intra‐car‐
diac	abnormalities	in	selected	cases	such	as	a	family	history	of	BAV.	
For	ongoing	 surveillance	of	patients	with	 aortic	dilatation,	 further	
research	 is	needed	to	determine	the	best	 imaging	strategy	for	on‐
going	surveillance.
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TA B L E  3  Ten	patients	with	a	clinically	relevant	arterial	abnormality	diagnosed	with	CT
Nr Age, gender






dissection Arterial abnomalitySoV AA Arch DA
1 28,	M 27 24 20 17 COL3a1 0 0 Dissection	renal	artery
2 58,	F 30 30 27 23 No 1 0 Dilation	pulmonary	artery	(32	mm)
3 66,	F 42 43 39 24 No 1 0 Dilation	pulmonary	artery	(45	mm)
4 69,	M 35 34 31 26 SMAD3 0 0 Dilation	pulmonary	artery	(33	mm)
5 48,	M 44 42 30 28 No 1 1 Dilation	pulmonary	artery	(35	mm)
6 60,	M 39 42 27 29 No 1 1 Dilation	pulmonary	artery	(40	mm)
7 75,	F * 48 33 29 No 1 1 Dilation	pulmonary	artery	(41	mm)
8 63,	F 33 38 40 27 No 1 1 Dilation	aortic	arch	(40	mm)
9 62,	M 32 34 28 28 No 0 0 Dilation	abdominal	aorta	(32	mm)
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